Literature DB >> 7057249

Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975.

L E Holm.   

Abstract

The incidence of hypothyroidism was analyzed in 4,553 hyperthyroid patients treated with I-131 between 1951 and 1975. The average annual rate of hypothyroidism during the first 7 yr after therapy increased continuously for each 5-yr period of treatment, from 3.6% for patients treated between 1951 and 1955 to 7.7% for patients treated during the period from 1971 though 1975 (p less than 0.001). The increase in the incidence of hypothyroidism was seen before the introduction of TSH assays and when allowance was made for thyroid gland size, the age of the patient, and the experience of the radiotherapist. The use of TSH assays has probably resulted in an earlier recognition of hypothyroidism, which may explain why the most marked rise in the incidence of hypothyroidism was observed after the introduction of TSH assays.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057249

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1991-03       Impact factor: 1.798

2.  Treatment of toxic multinodular goiter (Plummer's disease): surgery or radioiodine?

Authors:  M D Jensen; H Gharib; J M Naessens; J A van Heerden; W E Mayberry
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affecting the early induction of hypothyroidism.

Authors:  C C Alevizaki; M C Alevizaki-Harhalaki; D G Ikkos
Journal:  Eur J Nucl Med       Date:  1985

4.  The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.

Authors:  N R Peden; I R Hart
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.